drugset / Trial / NCT00849030
ATAC - Arimidex, Tamoxifen Alone or in Combination
RandomizedParallel-groupDouble-blindTreatment
Summary
The aim of this study is to test whether Arimidex alone or in combination with Tamoxifen is beneficial in the treatment of breast cancer.
Timeline
- Start
- 1996-07
- Primary completion
- 2001-06
- Completion
- 2010-04
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Anastozole | Unknown | 1 mg | Oral |
| Comparator | Tamoxifen | Small molecule | 20 mg | Oral |